Lupin's Sodium Zirconium Cyclosilicate ANDA217549 Receives AP Status from FDA
The FDA has granted approval status (AP) for Lupin's ANDA217549, which contains sodium zirconium cyclosilicate as the active ingredient.
Therapeutic Area
Therapeutic area intelligence for Hyperkalemia with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.